Sanofi says dengue vaccine works; 2015 launch anticipated
This article was originally published in Scrip
Executive Summary
Sanofi Pasteur, the vaccines division of Sanofi, has reported that its dengue fever vaccine has reached the primary endpoint in the first of two Phase III pivotal trials of the compound.